Juan González Del Castillo
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Emergency Service, Hospital | 30 | 2021 | 14232 | 1.13 | Why? |
| Sepsis | 6 | 2019 | 3517 | 0.75 | Why? |
| Actinomycosis | 1 | 2018 | 17 | 0.72 | Why? |
| Pneumocystis carinii | 1 | 2020 | 205 | 0.71 | Why? |
| Community-Acquired Infections | 4 | 2018 | 2328 | 0.68 | Why? |
| Inappropriate Prescribing | 2 | 2017 | 284 | 0.67 | Why? |
| Unsafe Sex | 1 | 2018 | 139 | 0.67 | Why? |
| Drug Resistance, Multiple | 1 | 2017 | 156 | 0.64 | Why? |
| Pneumonia | 5 | 2019 | 5652 | 0.62 | Why? |
| Osteomyelitis | 1 | 2018 | 131 | 0.62 | Why? |
| Guillain-Barre Syndrome | 4 | 2021 | 1495 | 0.61 | Why? |
| Pneumonia, Pneumococcal | 1 | 2019 | 251 | 0.60 | Why? |
| Pneumonia, Pneumocystis | 1 | 2020 | 322 | 0.60 | Why? |
| Spain | 23 | 2021 | 15545 | 0.55 | Why? |
| Post-Exposure Prophylaxis | 1 | 2018 | 472 | 0.51 | Why? |
| Organ Dysfunction Scores | 2 | 2018 | 1475 | 0.47 | Why? |
| Bacteremia | 2 | 2019 | 1372 | 0.44 | Why? |
| General Practitioners | 1 | 2018 | 568 | 0.41 | Why? |
| Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.41 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.41 | Why? |
| Emergency Medicine | 1 | 2020 | 936 | 0.40 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.37 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2018 | 6653 | 0.34 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.29 | Why? |
| Anti-Bacterial Agents | 6 | 2019 | 10083 | 0.28 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3832 | 0.27 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.26 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.24 | Why? |
| Pancreatitis | 2 | 2021 | 688 | 0.24 | Why? |
| Humans | 68 | 2022 | 930598 | 0.23 | Why? |
| Pneumothorax | 2 | 2020 | 758 | 0.23 | Why? |
| Symptom Assessment | 6 | 2020 | 4967 | 0.23 | Why? |
| Beds | 1 | 2021 | 79 | 0.22 | Why? |
| HIV | 2 | 2018 | 1116 | 0.22 | Why? |
| Antimicrobial Stewardship | 2 | 2019 | 931 | 0.21 | Why? |
| Frail Elderly | 3 | 2019 | 1427 | 0.20 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.20 | Why? |
| Prognosis | 11 | 2021 | 32490 | 0.19 | Why? |
| Emergencies | 2 | 2020 | 4095 | 0.19 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.19 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.19 | Why? |
| Tobramycin | 1 | 2018 | 18 | 0.18 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.18 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.18 | Why? |
| Meningoencephalitis | 1 | 2021 | 208 | 0.18 | Why? |
| HIV Seropositivity | 1 | 2020 | 320 | 0.18 | Why? |
| Gastrointestinal Hemorrhage | 2 | 2022 | 669 | 0.18 | Why? |
| Consensus | 4 | 2020 | 6345 | 0.17 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.17 | Why? |
| Hospital Mortality | 10 | 2021 | 22087 | 0.17 | Why? |
| ROC Curve | 3 | 2018 | 6024 | 0.16 | Why? |
| Heart Failure | 4 | 2019 | 6638 | 0.16 | Why? |
| Analysis of Variance | 1 | 2020 | 950 | 0.16 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.16 | Why? |
| Aged, 80 and over | 17 | 2021 | 88759 | 0.16 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.16 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.16 | Why? |
| Area Under Curve | 3 | 2019 | 2564 | 0.16 | Why? |
| Drug Resistance | 1 | 2018 | 395 | 0.15 | Why? |
| Ceftriaxone | 1 | 2018 | 365 | 0.15 | Why? |
| Clinical Protocols | 3 | 2021 | 2734 | 0.15 | Why? |
| Syncope | 1 | 2018 | 238 | 0.14 | Why? |
| Prospective Studies | 10 | 2020 | 43301 | 0.14 | Why? |
| Nutrition Assessment | 1 | 2019 | 527 | 0.14 | Why? |
| Pericarditis | 1 | 2020 | 417 | 0.14 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.14 | Why? |
| Hospitals, Public | 2 | 2020 | 774 | 0.14 | Why? |
| Risk Assessment | 5 | 2019 | 25439 | 0.14 | Why? |
| Hemostasis | 1 | 2021 | 811 | 0.14 | Why? |
| Diagnosis, Differential | 2 | 2020 | 7220 | 0.14 | Why? |
| Hospital Administration | 1 | 2021 | 650 | 0.13 | Why? |
| Acute Disease | 7 | 2021 | 6029 | 0.13 | Why? |
| Aged | 22 | 2021 | 215776 | 0.13 | Why? |
| Risk-Taking | 1 | 2018 | 508 | 0.13 | Why? |
| Patient Care Planning | 1 | 2019 | 582 | 0.13 | Why? |
| Hospitals, General | 1 | 2019 | 711 | 0.13 | Why? |
| Male | 30 | 2021 | 367725 | 0.13 | Why? |
| Pharyngitis | 1 | 2018 | 687 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.13 | Why? |
| Accidental Falls | 1 | 2017 | 448 | 0.12 | Why? |
| Sexual Partners | 1 | 2018 | 612 | 0.12 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Emergency Medical Services | 2 | 2020 | 3557 | 0.12 | Why? |
| Length of Stay | 3 | 2020 | 11042 | 0.12 | Why? |
| Psychotropic Drugs | 1 | 2017 | 396 | 0.12 | Why? |
| Advisory Committees | 1 | 2020 | 1418 | 0.12 | Why? |
| Female | 29 | 2021 | 380317 | 0.12 | Why? |
| Patient Discharge | 2 | 2019 | 5696 | 0.12 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.11 | Why? |
| Patient Transfer | 1 | 2019 | 898 | 0.11 | Why? |
| Biomarkers | 5 | 2019 | 23361 | 0.11 | Why? |
| Continuous Positive Airway Pressure | 1 | 2020 | 1187 | 0.11 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.11 | Why? |
| Cardiovascular Agents | 1 | 2017 | 663 | 0.11 | Why? |
| Retrospective Studies | 13 | 2022 | 105322 | 0.11 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.10 | Why? |
| Inflammation | 1 | 2013 | 13255 | 0.10 | Why? |
| Sports | 1 | 2018 | 690 | 0.10 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.10 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.10 | Why? |
| Malnutrition | 1 | 2019 | 932 | 0.10 | Why? |
| Research Personnel | 1 | 2020 | 1037 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.10 | Why? |
| Adult | 18 | 2021 | 244371 | 0.10 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Aftercare | 1 | 2019 | 1637 | 0.09 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.09 | Why? |
| Guidelines as Topic | 2 | 2018 | 2844 | 0.09 | Why? |
| Health Services Needs and Demand | 2 | 2020 | 3419 | 0.09 | Why? |
| Bacterial Infections | 2 | 2019 | 2229 | 0.09 | Why? |
| Quality Improvement | 1 | 2021 | 2435 | 0.09 | Why? |
| Sexual and Gender Minorities | 1 | 2018 | 1019 | 0.09 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.08 | Why? |
| Appendicitis | 1 | 2017 | 946 | 0.08 | Why? |
| Risk Factors | 10 | 2022 | 71621 | 0.08 | Why? |
| Acute Coronary Syndrome | 1 | 2021 | 2107 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Incidence | 7 | 2022 | 25622 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2017 | 1261 | 0.08 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.08 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.08 | Why? |
| Registries | 4 | 2020 | 12327 | 0.08 | Why? |
| Critical Care | 4 | 2021 | 14081 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.07 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.07 | Why? |
| Europe | 2 | 2021 | 12702 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Algorithms | 3 | 2020 | 7346 | 0.07 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.06 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.06 | Why? |
| Gastroscopy | 1 | 2022 | 112 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.05 | Why? |
| Matched-Pair Analysis | 1 | 2019 | 83 | 0.05 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.05 | Why? |
| Diagnosis-Related Groups | 1 | 2020 | 167 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Drug Resistance, Bacterial | 2 | 2019 | 1414 | 0.05 | Why? |
| Absenteeism | 1 | 2020 | 287 | 0.05 | Why? |
| Calcitonin | 1 | 2019 | 201 | 0.04 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Stroke | 1 | 2021 | 8839 | 0.04 | Why? |
| Confidence Intervals | 1 | 2020 | 744 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.04 | Why? |
| Lactic Acid | 1 | 2019 | 393 | 0.04 | Why? |
| Child | 6 | 2021 | 70012 | 0.04 | Why? |
| Drug Therapy | 1 | 2018 | 280 | 0.04 | Why? |
| Health Resources | 2 | 2020 | 2592 | 0.04 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.04 | Why? |
| Patient Admission | 1 | 2012 | 5250 | 0.04 | Why? |
| Latin America | 1 | 2021 | 1721 | 0.04 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.03 | Why? |
| Models, Statistical | 1 | 2012 | 5312 | 0.03 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
| Respiration Disorders | 1 | 2020 | 526 | 0.03 | Why? |
| Disability Evaluation | 1 | 2017 | 671 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Checklist | 1 | 2019 | 714 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.03 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.03 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.02 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.02 | Why? |
| Kidney Diseases | 1 | 2020 | 1434 | 0.02 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.02 | Why? |
| Practice Guidelines as Topic | 1 | 2013 | 15421 | 0.02 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.02 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Cardiovascular Diseases | 2 | 2021 | 11497 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.02 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.01 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.01 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Forecasting | 1 | 2012 | 4492 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Critical Illness | 1 | 2019 | 17281 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.01 | Why? |